To determine the effect of Glipr1 on MM tumour growth in vivo, the 5TGM1-Glipr1 and 5TGM1-EV cell lines were injected intravenously into KaLwRij mice and tumour burden was monitored at weekly intervals by bioluminescence imaging. The gene discussed is GLIPR1; the disease is Miyoshi myopathy.